Prosecution Insights
Last updated: November 13, 2026
Application No. 17/793,405

A Method of Manufacturing An External Breast Prosthesis and Said Prosthesis

Non-Final OA §102§103
Filed
Jul 17, 2022
Priority
Jan 17, 2020 — NL 2024687 +1 more
Examiner
THROWER, LARRY W
Art Unit
1754
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Christiaan Mathias Hubertus Gerard Reutelingsperger
OA Round
4 (Non-Final)
66%
Grant Probability
Favorable
4-5
OA Rounds
78%
With Interview

Examiner Intelligence

Grants 66% — above average
66%
Career Allowance Rate
642 granted / 976 resolved
+0.8% vs TC avg
Moderate +12% lift
Without
With
+12.4%
Interview Lift
resolved cases with interview
Typical timeline
Avg Prosecution
48 currently pending
Career history
1039
Total Applications
across all art units

Office Action

§102 §103
Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . The amendment filed August 31, 2026 has been entered. Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. (a)(2) the claimed invention was described in a patent issued under section 151, or in an application for patent published or deemed published under section 122(b), in which the patent or application, as the case may be, names another inventor and was effectively filed before the effective filing date of the claimed invention. Claims 1 and 7 are rejected under 35 U.S.C. 102(a)(1) and 102(a)(2) as being anticipated by Ketchum (US 2017/0281367). Claim 1: Ketchum discloses a method of manufacturing an external breast prosthesis (¶¶ 60, 65, 107). The method includes providing a 3D image of the prosthesis (¶¶ 65, 102, 105), and forming the prosthesis using an additive manufacturing process (¶¶ 65, 69, 105), in which additive manufacturing process the breast prosthesis is made by forming a structure of a polymer (¶¶ 53, 65, 105), the structure corresponding to the 3D image of the prosthesis (¶¶ 65, 102, 105), the structure having an inner wall and an outer wall (¶¶ 55, 103), wherein the polymer used is a thermoplastic elastomer (¶ 53), and the structure is formed as a reticulated solid foam having pores being continuous from the inner wall to the outer wall of the prosthesis (¶¶ 54-57, 77, 103, 106), to allow air to freely penetrate completely through the structure (¶ 57). Claim 7: Ketchum discloses the additive manufacturing is performed using a 3D printing technology (¶¶ 69, 71, 105). Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claims 2-3 are rejected under 35 U.S.C. 103 as being unpatentable over Ketchum (US 2017/0281367), as applied to claim 1 above, in view of Mao (CN 107638231; paragraph numbers to attached English language translation). Claim 2: Ketchum is silent as to the claimed porosity ranges. However, in the same field of endeavor, Mao discloses a breast prosthesis wherein the porosity of the reticulated solid foam is 50-80% (¶ 35). It would have been obvious to one having ordinary skill in the art to utilized the porosity range of Mao in the prosthesis of Ketchum to obtain the desired compliance and support, adjusting member dimensions and spacing while retaining the open pore network. Claim 3: The range of Mao overlaps the claimed range. Where ranges overlap, a prima facie case of obviousness is made out). In re Boesch, 617 F.2d 272, 275 (CCPA 1980). See also In re Peterson, 315 F.3d 1325, 1329 (Fed. Cir. 2003) (a prima facie case of obviousness exists when the ranges of a claimed composition overlap the ranges disclosed in the prior art) and In re Harris, 409 F.3d 1339, 1341 (Fed. Cir. 2005) (same). Claims 5-6 are rejected under 35 U.S.C. 103 as being unpatentable over Ketchum (US 2017/0281367), as applied to claim 1 above, in view of Laghi (US 2009/0183822) and Guillemette (Rapid isothermal substrate microfabrication of a biocompatible thermoplastic elastomer for cellular contact guidance, Acta Biomaterialia, Volume 7, Issue 6, 2011, Pages 2492-2498). Claim 4: Ketchum is silent as to the thermoplastic elastomer being a non-biodegradable polymer. However, in the same field of endeavor, Laghi discloses an external breast prosthesis including SEBS (¶ 33). As taught by Laghi, utilizing SEBS in the manufacture of breast prostheses provides the texture, appearance and elasticity of a normal human breast (¶ 10). Guillemette discloses the need for non-biodegradable biocompatible articles made from SEBS with good tissue functionality (abstract). It would have been obvious to one having ordinary skill in the art prior to the effective filing date of the application to have utilized a SEBS elastomer in the method of Ketchum to provide the prosthesis with the texture, appearance and elasticity of a normal human breast, and particularly the non-biodegradable SEBS elastomer of Guillemette for the good tissue functionality. Claims 5-6 are rejected under 35 U.S.C. 103 as being unpatentable over Ketchum (US 2017/0281367), as applied to claim 1 above, in view of Laghi (US 2009/0183822). Claim 5: Ketchum is silent as to the thermoplastic elastomer being a styrene block copolymer. However, in the same field of endeavor, Laghi discloses an external breast prosthesis including SEBS (¶ 33). As taught by Laghi, utilizing SEBS in the manufacture of breast prostheses provides the texture, appearance and elasticity of a normal human breast (¶ 10). It would have been obvious to one having ordinary skill in the art prior to the effective filing date of the application to have utilized the elastomer of Laghi in the method of Ketchum to provide the prosthesis with the texture, appearance and elasticity of a normal human breast. Claims 8-9 are rejected under 35 U.S.C. 103 as being unpatentable over Ketchum (US 2017/0281367), as applied to claim 1 above, in view of Sun (US 2009/0148813). Ketchum is silent as to using inkjet technology. However, in the same field of endeavor of manufacturing prosthetics using additive manufacturing, Sun discloses depositing polymer droplets that fuse together after being deposited as part of the inkjet deposition technology (¶ 125). As taught by Sun, utilizing inkjet deposition achieves good dimensional stability and advantageous mechanical integrity. It would have been obvious to one of ordinary skill in the art prior to the effective filing date of the application to have included the inkjet deposition technology of Sun in the method of Ketchum in order to achieve good dimensional stability and better mechanical integrity of the prosthetic. Claims 10-12 are rejected under 35 U.S.C. 103 as being unpatentable over Ketchum (US 2017/0281367), as applied to claim 1 above, in view of Kelley (US 2014/0309750). Ketchum is silent as to thermal conductors. However, in the same field of endeavor of manufacturing prosthetics, Kelley discloses a method of manufacturing prosthetics that includes elongated thermal conductors (¶¶ 70-72). As taught by Kelley, including enhanced thermal conductivity in a prosthetic enhances heat absorption capabilities (¶ 70). It would have been obvious to one of ordinary skill in the art prior to the effective filing date of the application to have included the thermal conductors of Kelley in the method of Ketchum in order to enhance heat absorption capabilities of the prosthetic. Response to Arguments Applicant’s arguments with respect to the claims have been considered but are moot in view of the new grounds of rejection. Conclusion Applicant's amendment necessitated the new ground(s) of rejection presented in this Office action. Accordingly, THIS ACTION IS MADE FINAL. See MPEP § 706.07(a). Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to LARRY THROWER whose telephone number is (571)270-5517. The examiner can normally be reached 9am-5pm MT M-F. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Susan Leong can be reached at 571-270-1487. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /LARRY W THROWER/ Primary Examiner, Art Unit 1754
Read full office action

Prosecution Timeline

Show 3 earlier events
Feb 26, 2026
Final Rejection mailed — §102, §103
May 12, 2026
Response after Non-Final Action
May 19, 2026
Request for Continued Examination
May 22, 2026
Response after Non-Final Action
Jun 01, 2026
Non-Final Rejection mailed — §102, §103
Aug 31, 2026
Response Filed
Sep 21, 2026
Final Rejection mailed — §102, §103
Nov 06, 2026
Response after Non-Final Action

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12789454
BUILD-PLATE USED IN FORMING DEVICES AND LOCATING FEATURES FORMED ON THE BUILD-PLATE TO FACILITATE USE OF ADDITIVE AND SUBTRACTIVE MANUFACTURING PROCESSES AND METHOD FOR USE THEREOF
3y 8m to grant Granted Nov 10, 2026
Patent 12779784
CONFIGURING LAYER GENERATION TIME IN ADDITIVE MANUFACTURING
8y 2m to grant Granted Nov 03, 2026
Patent 12759219
ONE PART MOISTURE CURABLE RESINS FOR ADDITIVE MANUFACTURING
4y 1m to grant Granted Oct 13, 2026
Patent 12763312
AUTOMATED FOLDING CALENDER FOR ELECTRODE MANUFACTURING
2y 3m to grant Granted Oct 13, 2026
Patent 12752223
METHOD FOR ADJUSTING GROUTING PARAMETERS IN PREPARATION OF CERAMIC COMPOSITE FIBER-BASED CATALYTIC FILTER TUBE, AND METHOD AND DEVICE FOR PREPARING CERAMIC COMPOSITE FIBER-BASED CATALYTIC FILTER TUBE
3y 6m to grant Granted Oct 06, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

4-5
Expected OA Rounds
66%
Grant Probability
78%
With Interview (+12.4%)
High
PTA Risk
Based on 976 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month